Editorial: Intellectual Disabilities in Down Syndrome from Birth and Throughout Life: Assessment and Treatment

Affiliations

¹ Centre National de la Recherche Scientifique UMR 7225, Institut National de la Santé et de la Recherche Médicale, U1127, Institut du Cerveau et de la Moelle, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127 Paris, France.
² Department of Physiology and McKusick Nathans Institute for Genetic Medicine, Johns Hopkins University School of Medicine Baltimore, MD, USA.

Marie-Claude Potier et al. Front Behav Neurosci. 2016.

. 2016 Jun 14:10:120.

doi: 10.3389/fnbeh.2016.00120. eCollection 2016.

¹ Centre National de la Recherche Scientifique UMR 7225, Institut National de la Santé et de la Recherche Médicale, U1127, Institut du Cerveau et de la Moelle, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127 Paris, France.
² Department of Physiology and McKusick Nathans Institute for Genetic Medicine, Johns Hopkins University School of Medicine Baltimore, MD, USA.

No abstract available

Keywords: Alzheimer's disease; GABA; down syndrome; intellectual disabilities; language; prenatal; treatment.

Comment on

The Editorial on the Research Topic Intellectual Disabilities in Down Syndrome from Birth and Throughout Life: Assessment and Treatment

1. Dekker A. D., Coppus A. M., Vermeiren Y., Aerts T., van Duijn C. M., Kremer B. P., et al. (2015). Serum MHPG strongly predicts conversion to Alzheimer's disease in behaviorally characterized subjects with Down syndrome. J. Alzheimers. Dis. 43, 871–891. 10.3233/JAD-140783 - DOI - PubMed